<main class="html-publication" lang="en" role="main">
      

  <div class="publication-external">
    <ul class="organisation-logos">
        <li class="organisation-logos__logo">
          
<div class="gem-c-organisation-logo brand--home-office">
    <a class="gem-c-organisation-logo__container gem-c-organisation-logo__link gem-c-organisation-logo__crest gem-c-organisation-logo__crest--ho brand__border-color" href="/government/organisations/home-office">
      <span class="gem-c-organisation-logo__name">Home Office</span>
</a>
</div>
        </li>
    </ul>
  </div>

  <header class="gem-c-inverse-header  gem-c-inverse-header--padding-top ">
    
  

<div class="gem-c-title gem-c-title--inverse govuk-!-margin-top-8 govuk-!-margin-bottom-0">
      <span class="govuk-caption-xl gem-c-title__context">
    Guidance
  </span>


  <h1 class="gem-c-title__text govuk-heading-xl">
    List of most commonly encountered drugs currently controlled under the misuse of drugs legislation
  </h1>
</div>
  <p class="publication-header__last-changed">Updated 8 August 2022</p>

  </header>






<div class="sidebar-with-body">
  <div class="govuk-grid-row">

    <div class="print-wrapper">
      <div class="print-meta-data">
        <p>
  <img class="print-meta-data-licence" src="/assets/government-frontend/open-government-licence-min-93b6a51b518ff99714a1aa2a7d2162735c155ec3cb073c75fb88b2a332fa83d3.png">
</p>
<p>
  © Crown copyright 2022
</p>
<p>
  This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit <a href="https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3">nationalarchives.gov.uk/doc/open-government-licence/version/3</a> or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: <a href="mailto:psi@nationalarchives.gov.uk">psi@nationalarchives.gov.uk</a>.
</p>
<p>
  Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
</p>
<p>
  This publication is available at https://www.gov.uk/government/publications/controlled-drugs-list--2/list-of-most-commonly-encountered-drugs-currently-controlled-under-the-misuse-of-drugs-legislation
</p>


      </div>
    </div>

    <div class="main-content-container offset-empty-contents-list">
      <div class="gem-c-govspeak-html-publication">
  
<div class="gem-c-govspeak govuk-govspeak " data-module="govspeak">
    
    
        <div class="govspeak">
<p>The following is a list of the most commonly encountered drugs currently controlled under the misuse of drugs legislation showing their respective classifications under both the Misuse of Drugs Act 1971 (MDA) and the Misuse of Drugs Regulations 2001 (MDR).</p>

<p>Although it is extensive, the list is not exhaustive and, in the event of a substance not being listed below, reference should also be made to the published Act and Regulations at legislation.gov.uk, specifically Parts I, II, III and IV of <a class="govuk-link" href="http://www.legislation.gov.uk/ukpga/1971/38/schedule/2" rel="external">Schedule 2 to the Misuse of Drugs Act 1971</a> and in Schedules 1 to 5 to the <a class="govuk-link" href="http://www.legislation.gov.uk/uksi/2001/3998/pdfs/uksi_20013998_en.pdf" rel="external">Misuse of Drugs Regulations 2001</a>.</p>

<p>Please note that on opening the content of any item of legislation that has outstanding changes and effects waiting to be applied to it, the outstanding effects are listed at the top of the provision.</p>

<p>This list is not exhaustive. All salts (e.g. calcium, HCl, sodium and sulphate), stereoisomers, esters, ethers, preparations and products are also controlled where stated in the legislation.</p>

<table>
  <thead>
    <tr>
      <th scope="col">Drug</th>
      <th scope="col">Class</th>
      <th scope="col">Schedule</th>
    </tr>
    <tr>
      <td></td>
      <th scope="col">MDA</th>
      <th scope="col">MDR</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Acetorphine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Acetyldihydrocodeine</td>
      <td>B<sup role="doc-noteref"><a class="govuk-link" href="#fn:1" rel="footnote">[footnote 1]</a></sup>
</td>
      <td>2/5<sup role="doc-noteref"><a class="govuk-link" href="#fn:2" rel="footnote">[footnote 2]</a></sup>
</td>
    </tr>
    <tr>
      <td>Adinazolam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Alfentanil</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Allobarbital (allobarbitone)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Allyl(α-methyl-3,4-methylenedioxyphenethyl)amine (MDAL)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Allylprodine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Alphacetylmethadol</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Alphameprodine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Alphamethadol</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>α-Methylfentanyl</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Alphaprodine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Alphenal (5-Allyl-5-Phenylbarbituric acid)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Alprazolam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Amineptine</td>
      <td>C</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Aminorex</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Amphetamine</td>
      <td>B<sup role="doc-noteref"><a class="govuk-link" href="#fn:1" rel="footnote">[footnote 1]</a></sup>
</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Amobarbital (Amylobarbitone)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Androst-4-ene-3,17-diol (4-Androstenediol)</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Anhydroecgonine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Anileridine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Aprobarbital (Aprobarbitone)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Atamestane</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Barbital (Barbitone)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Barbituric acid, (any 5,5-disubstituted)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Benzethidine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Benzoylecgonine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Benzphetamine</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Benzyl(α-Methyl-3,4-methylenedioxyphenethyl)amine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Benzylmorphine (3-Benzylmorphine)</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Betacetylmethadol</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Betameprodine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Betamethadol</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>β-Methoxy-3,4-methylenedioxyphenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Betaprodine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Bezitramide</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Bolandiol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Bolasterone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Bolazine</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Boldenone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Boldione</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Bolenol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Bolmantalate</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Bromazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Bromazolam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Bromophenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Brotizolam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Bufotenine (5-Methoxydimethyltryptamine)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Buprenorphine</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Butabarbital (Secbutobarbital)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Butalbital</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Butallylonal</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Butethal (Butobarbital/Butobarbitone)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Calusterone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Camazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Cannabinol</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Cannabinol derivatives (except dronabinol or its stereoisomers)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Cannabis</td>
      <td>B</td>
      <td>1<sup role="doc-noteref"><a class="govuk-link" href="#fn:11" rel="footnote">[footnote 11]</a></sup>
</td>
    </tr>
    <tr>
      <td>cannabis resin</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>cannabis oil</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>“Sativex”</td>
      <td>B</td>
      <td>4 Pt1<sup role="doc-noteref"><a class="govuk-link" href="#fn:10" rel="footnote">[footnote 10]</a></sup>
</td>
    </tr>
    <tr>
      <td>Carfentanyl (Carfentanil)</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Cathine ((+)-norpseudoephedrine)</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Cathinone</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Cathinone derivatives</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>CBPMs</td>
      <td>B</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Chlordiazepoxide</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Chloromethamphetamine</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Chloroamphetamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Chlorphentermine</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Chlorophenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Chorionic gonadotrophin (HCG)</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Clenbuterol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Clobazam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Clonazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Clonazolam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Clonitazene</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Clorazepic acid (Clorazepate)</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Clostebol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Clotiazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Cloxazolam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Coca leaf</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Cocaethylene (ethylbenzoylecgonine)</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Cocaine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Codeine</td>
      <td>B<sup role="doc-noteref"><a class="govuk-link" href="#fn:1" rel="footnote">[footnote 1]</a></sup>
</td>
      <td>2/5<sup role="doc-noteref"><a class="govuk-link" href="#fn:2" rel="footnote">[footnote 2]</a></sup>
</td>
    </tr>
    <tr>
      <td>Cyclobarbital (Cyclobarbitone)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Cyclopentobarbital (Cyclopentobarbitone)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Cyclopropylmethyl(α-Methyl-3,4-methylenedioxyphenethyl)amine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Danazol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Delorazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Deschloroetizolam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Desomorphine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Desoxymethyltestosterone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Desoxypipradrol (2-Diphenylmethyl-piperidine, 2-DPMP)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Dextromoramide</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Dextropropoxyphene</td>
      <td>C</td>
      <td>2/5<sup role="doc-noteref"><a class="govuk-link" href="#fn:3" rel="footnote">[footnote 3]</a></sup>
</td>
    </tr>
    <tr>
      <td>Diamorphine (Diacetylmorphine)</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Diampromide</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Diazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Diclazepam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Diethylpropion</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Diethylthiambutene</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Difenoxin</td>
      <td>A</td>
      <td>2/5<sup role="doc-noteref"><a class="govuk-link" href="#fn:4" rel="footnote">[footnote 4]</a></sup>
</td>
    </tr>
    <tr>
      <td>Dihydrocodeine</td>
      <td>B<sup role="doc-noteref"><a class="govuk-link" href="#fn:1" rel="footnote">[footnote 1]</a></sup>
</td>
      <td>2/5<sup role="doc-noteref"><a class="govuk-link" href="#fn:2" rel="footnote">[footnote 2]</a></sup>
</td>
    </tr>
    <tr>
      <td>Dimethyl(α-methyl-3,4-methylenedioxyphenethyl)amine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>α,α-Dimethyl-3,4-methylenedioxyphenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>α,α-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Dihydrocodeinone-O-carboxymethyloxime</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Dihydroetorphine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Dihydromorphine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Dimenoxadole</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Dimepheptanol</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Dimethylthiambutene</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Dioxaphetyl butyrate</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Diphenoxylate</td>
      <td>A</td>
      <td>2/5<sup role="doc-noteref"><a class="govuk-link" href="#fn:5" rel="footnote">[footnote 5]</a></sup>
</td>
    </tr>
    <tr>
      <td>Diphenylprolinol (Diphenyl-2-pyrrolidinyl-methanol, D2PM)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Dipipanone</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Dronabinol</td>
      <td>B</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Drotebanol (3,4-Dimethoxy-17-methylmorphinan- 6, 14-diol)</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Drostanolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Ecgonine and any derivative of ecgognine which is convertible to ecgonine or cocaine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Enestebol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Epidyolex</td>
      <td>B</td>
      <td>5</td>
    </tr>
    <tr>
      <td>Epitiostanol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Estazolam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Ethchlorvynol</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Ethinamate</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Ethyl loflazepate</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Ethylmethylthiambutene</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Ethylmorphine (3-Ethylmorphine)</td>
      <td>B<sup role="doc-noteref"><a class="govuk-link" href="#fn:1" rel="footnote">[footnote 1]</a></sup>
</td>
      <td>2<sup role="doc-noteref"><a class="govuk-link" href="#fn:2" rel="footnote">[footnote 2]</a></sup>
</td>
    </tr>
    <tr>
      <td>Ethylnaphthidate</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Ethyloestrenol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Ethylphenidate</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Eticyclidine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Etizolam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Etonitazene</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Etorphine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Etoxeridine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Etryptamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Fencamfamin</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Fenethylline</td>
      <td>C</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Fenproporex</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Fentanyl</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Flualprazolam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Flubromazepam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Flubromazolam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Fludiazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Flunitrazepam</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Flunitrazolam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Fluorophenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Fluoxymesterone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Flurazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Fonazepam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Formebolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Fungus (of any kind) which contains psilocin or an ester of psilocin</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Furazabol</td>
      <td>C</td>
      <td>4Pt2</td>
    </tr>
    <tr>
      <td>Furethidine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Gabapentin (1-(aminomethyl) cyclohexaneacetic acid)</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Gamma-butyrolactone (GBL) (for human ingestion)</td>
      <td>B</td>
      <td>n/a<sup role="doc-noteref"><a class="govuk-link" href="#fn:9" rel="footnote">[footnote 9]</a></sup>
</td>
    </tr>
    <tr>
      <td>Gamma-hydroxybutyrate (GHB - 4-Hydroxy-n-butyric acid)</td>
      <td>B</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Gestrinone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Glutethimide</td>
      <td>B</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Halazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Haloxazolam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Heptobarbital (Heptobarbitone)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Hexethal</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Homoveratrylamine (3,4-Dimethoxyphenethylamine)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Hydroxybenzoylecgonine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Hydroxycocaine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Hydrocodone (dihydrocodeinone)</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Hydromorphinol (14-Hydroxydihydromorphine)</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Hydromorphone</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Hydroxypethidine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Isomethadone</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Isopropylphenidate</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Ketamine</td>
      <td>B</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Ketazolam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Ketobemidone</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Khat</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Lefetamine</td>
      <td>B</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Levomethorphan</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Levomoramide</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Levophenacylmorphan</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Levorphanol/Dextrorphan</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Lisdexamphetamine</td>
      <td>B</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Lofentanil</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Loprazolam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Lorazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Lormetazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Lysergamide</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Lysergic acid diethylamide (LSD)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Lysergic Acid N-(Methylopropyl) Amide</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Lysergide (&amp; other N-alkyl derivatives of lysergamide)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Mazindol</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Mebolazine</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Meclonazepam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Mecloqualone</td>
      <td>B</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Medazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Mefenorex</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Mephentermine</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Mepitiostane</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Meprobamate</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Mesabolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Mescaline</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Mesocarb</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Mestanolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Metazocine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Mesterolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Methadone</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Methadyl acetate</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Methylamphetamine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Methylmorphenate</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Methylnaphthidate</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>α-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>α-Methylphenethylhydroxylamine</td>
      <td>B</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Methandienone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Methandriol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Methaqualone</td>
      <td>B</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Methcathinone (Ephedrone)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Methenolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Methoxyphenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Methyldesorphine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Methyldihydromorphine (6-methyldihydromorphine)</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Methylecgonine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Methylenedioxyamphetamine (MDA)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Methylenedioxyethylamphetamine (MDEA)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Methylenedioxypyrovalerone (MDPV)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Methylphenidate</td>
      <td>B<sup role="doc-noteref"><a class="govuk-link" href="#fn:1" rel="footnote">[footnote 1]</a></sup>
</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Methylphenobarbital (Methylphenobarbitone)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Methyltestosterone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Methyprylone</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Metizolam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Metopon</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Metribolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Mibolerone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Midazolam</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Morpheridine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Morphine</td>
      <td>A</td>
      <td>2/5<sup role="doc-noteref"><a class="govuk-link" href="#fn:6" rel="footnote">[footnote 6]</a></sup>
</td>
    </tr>
    <tr>
      <td>3-Monoacetylmorphine (3-MAM)</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>6-Monoacetylmorphine (6-MAM)</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Morphine-3-B-D-Glucoride-N-Oxide</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Morphine-3-B-D-Glucuronide</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Morphine-6-B-D-glucuronide-N-oxide</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Morphine methobromide (&amp; morphine N-oxide &amp; other pentavalent nitrogen morphine derivatives)</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Myrophine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>N-Benzyl-ethylphenidate</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>N-Benzylpethidine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>N-(2,5-Dimethoxy-4-propylthiophenthyl)hydroxylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>N,N-Diethyltryptamine (DET)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>N,N-Dimethyltryptamine (DMT)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>N-Ethylamphetamine</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>N-Ethyl-1(3-methoxyphenyl)cyclohexylamine (3-MeO-PCE)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>N-Hydroxy-tenamphetamine (MDOH)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>N-Methylhomoveratrylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>N-Methyl Lysergic Acid Diethylamide</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>N-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>N-Methyltryptamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Nabilone</td>
      <td>B</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Nandrolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Napthylpyrovalerone (naphyrone)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Nealbarbitone</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>N-ethyl-nor-ketamine</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Nicocodine</td>
      <td>B<sup role="doc-noteref"><a class="govuk-link" href="#fn:1" rel="footnote">[footnote 1]</a></sup>
</td>
      <td>2/5<sup role="doc-noteref"><a class="govuk-link" href="#fn:2" rel="footnote">[footnote 2]</a></sup>
</td>
    </tr>
    <tr>
      <td>Nicodicodine (6-nicotinoyldihydrocodeine)</td>
      <td>B<sup role="doc-noteref"><a class="govuk-link" href="#fn:1" rel="footnote">[footnote 1]</a></sup>
</td>
      <td>2/5<sup role="doc-noteref"><a class="govuk-link" href="#fn:2" rel="footnote">[footnote 2]</a></sup>
</td>
    </tr>
    <tr>
      <td>Nicomorphine (3,6-dinicotinoyl-morphine)</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Nifoxipam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Nimetazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Nitrazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Nitrazolam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Non-human chorionic gonadotrophin</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Noracymethadol</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Norboletone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Norclostebol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Norcocaine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Norcodeine</td>
      <td>B<sup role="doc-noteref"><a class="govuk-link" href="#fn:1" rel="footnote">[footnote 1]</a></sup>
</td>
      <td>2/5<sup role="doc-noteref"><a class="govuk-link" href="#fn:2" rel="footnote">[footnote 2]</a></sup>
</td>
    </tr>
    <tr>
      <td>Nordazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Norethandrolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Norfludiazepam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Norlevorphanol</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Normethadone</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Normorphine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Norpethidine (4-Phenylpiperidine-4-carboxylic acid ethyl ester)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Norpipanone</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>O-Methyl-N-(α-methyl-3,4-methylenedioxyphenethyl)hydroxylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Opium:</td>
      <td>&nbsp;</td>
      <td>&nbsp;</td>
    </tr>
    <tr>
      <td>Raw</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Prepared or medicinal</td>
      <td>A</td>
      <td>2<sup role="doc-noteref"><a class="govuk-link" href="#fn:6" rel="footnote">[footnote 6]</a></sup><sup role="doc-noteref"><a class="govuk-link" href="#fn:7" rel="footnote">[footnote 7]</a></sup>
</td>
    </tr>
    <tr>
      <td>Oripavine</td>
      <td>C</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Ovandrotone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Oxabolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Oxandrolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Oxazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Oxazolam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Oxycodone</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Oxymesterone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Oxymetholone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Oxymorphone</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Pemoline</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Pentazocine</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Pentobarbital (Pentobarbitone)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Pethidine (Meperidine)</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Phenadoxone</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Phenampromide</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Phenazepam (7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Phenazocine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Phencyclidine (PCP)</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Phendimetrazine</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Phenmetrazine</td>
      <td>B<sup role="doc-noteref"><a class="govuk-link" href="#fn:1" rel="footnote">[footnote 1]</a></sup>
</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Phenobarbital (Phenobarbitone)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Phenomorphan</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Phenoperidine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Phentermine</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Pholcodine (Morpholinylethylmorphine)</td>
      <td>B<sup role="doc-noteref"><a class="govuk-link" href="#fn:1" rel="footnote">[footnote 1]</a></sup>
</td>
      <td>2/5<sup role="doc-noteref"><a class="govuk-link" href="#fn:2" rel="footnote">[footnote 2]</a></sup>
</td>
    </tr>
    <tr>
      <td>Piminodine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Pinazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Pipradrol</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Piritramide</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Poppy straw (and concentrate)</td>
      <td>A</td>
      <td>n/a</td>
    </tr>
    <tr>
      <td>Prasterone (Dehydroepiandrosterone DHEA)</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Prazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Pregabalin ((S)–3–(aminomethyl)-5-methylhexanoic acid)</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Probarbital (Probarbitone)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Proheptazine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Propallylonal</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Properidine (1-methyl-4-phenyl-piperidine-4-carboxylic acid isopropyl ester)</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Propetandrol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Propiram</td>
      <td>B</td>
      <td>2/5<sup role="doc-noteref"><a class="govuk-link" href="#fn:8" rel="footnote">[footnote 8]</a></sup>
</td>
    </tr>
    <tr>
      <td>Propylbenzoylecgonine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Propylphenidate</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Prostanozol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Proxibarbital (Proxibarbitone)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Psilocin</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Pyrazolam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Pyrovalerone</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Quinalbarbital (Quinalbarbitone/Secobarbital)</td>
      <td>B</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Quinbolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Racemethorphan</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Racemoramide</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Racemorphan</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Remifentanil</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Rolicyclidine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Roxibolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Secbutobarbital (Secbutobarbitone)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Silandrone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Somatotropin</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Somatrem</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Somatropin</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Stanolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Stanozolol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Stenbolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Sufentanil</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Talbutal</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Tapentadol</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Temazepam</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Tenocyclidine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Testosterone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Tetrahydrocannabinol (Delta-THC)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Tetrahydrogestrinone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Tetrazepam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Thebacon (acetyldihydrocodeinone)</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Thebaine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Thiomesterone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Tilidine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Tramadol</td>
      <td>C</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Trenbolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Triazolam</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Trimeperidine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>U-47,700</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>Vinbarbital (Vinbarbitone)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Vinylbital (Vinylbitone)</td>
      <td>B</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Zaleplon</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Zeranol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Zilpaterol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>Zipeprol</td>
      <td>B</td>
      <td>2</td>
    </tr>
    <tr>
      <td>Zolpidem</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>Zopiclone</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>1-Androstenediol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>1-Androstenedione</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>1-Benzylpiperazine (BZP)</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-(Benzofuran-5-yl)-propan-2-amine (5-APB)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-(Benzofuran-6-yl)-propan-2-amine (6-APB)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-Benzyl-4-methylpiperazine (BZMP)</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1,4-Butanediol (1,4-BD) (for human ingestion)</td>
      <td>B</td>
      <td>n/a<sup role="doc-noteref"><a class="govuk-link" href="#fn:9" rel="footnote">[footnote 9]</a></sup>
</td>
    </tr>
    <tr>
      <td>1-(3-Chlorophenyl)-4-(3-chloropropyl)piperazine (CPCPP)</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>1-(3-Chlorophenyl)piperazine (mCPP)</td>
      <td>C</td>
      <td>4 Pt1</td>
    </tr>
    <tr>
      <td>1-(4-Chlorophenyl)piperazine (pCPP)</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1,4-Dibenzylpiperazine (DBZP)</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-(2,3-Dihydro-1-benzofuran-5-yl)-propan-2-amine (5-APDB)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-(2,3-Dihydro-1-benzofuran-6-yl)-propan-2-amine  (6-APDB)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-(4-Fluorophenyl)piperazine (pFPP)</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-(5-Fluoropentyl)-3-(4-methyl-naphthoyl)indole (MAM-2201)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole (AM-694)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-(5-Fluoropentyl)-3-(naphthalen-1-oyl)indole (AM-2201)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-Methyl-4-phenylpiperidine-4-carboxylic acid</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-(3-Methylphenyl)piperazine (mMPP)</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-(4-Methoxyphenyl)piperazine (pMeOPP)</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-[1-(3-Methoxyphenyl)cyclohexyl]-piperidine (3-MeO-PCP)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-[1-(4-Methoxyphenyl)cyclohexyl]-piperidine (4-MeO-PCP)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-(4- Methylphenyl)piperazine (pMPP)</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-Pentyl-3-(2-iodobenzoyl)indole (AM-679)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-Pentyl-3-(2,2,3,3-tetramethylcyclopropylcarbonyl)indole (UR-144)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>1-(3-Trifluoromethylphenyl)piperazine (TFMPP)</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-Amino-1-(3,4-dimethoxyphenyl)ethanol</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl] ethanamine (25B-NBOMe)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-Chloro-6-fluorophenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(1,4-Dimethoxy-2-naphthyl)ethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2,5-Dimethoxy-4-(N)-propylthiophenethylamine (2C-T-7)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(3,4-Dimethoxyphenyl)ethylamine (Homoveratrylamine)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2,4-Dichlorophenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2,4-Dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl}methanone (LSZ)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2,5-Dimethoxy-4-Bromoamphetamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2,5-Dimethoxy-4-Iodoamphetamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2,5-Dimethoxy-4-Methylamphetamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2,5-Dimethoxy--4-dimethylphenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2,5-Dimethoxy-4-iodoamphetamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(2,5-Dimethoxy-4-methylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25D-NBOMe)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-((Dimethylamino)methyl)-1-(3-hydroxyphenyl)cyclohexanol (O-Desmethyltramadol)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2,6-Dichlorophenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-Diphenylmethylpyrrolidine</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone (Methoxetamine)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(5-Methoxy-2-methyl-2,3-dihydrobenzo[β]furan-6-yl)-1-methylethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo[β]furan-6-yl)-1-methylethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(α-Methyl-3,4-methylenedioxyphenethylamino)ethanol</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-Methoxyethyl(α-methyl-3,4-methylenedioxyphenethyl)amine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-(2-Methoxyphenyl)-2-(methylamino)cyclohexanone</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-Methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>2-Methylamino-1-(3,4-methylenedioxyphenyl)butan-1-one (butylone)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>2-Methylamino-1-(3,4-methylenedioxyphenyl)propan-1-one (methylone)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>β,2,5-Trimethoxy-4-methylphenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>3,4-Dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>3-Fluoromethcathinone (3-FMC)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>3-Hydroxyphenazepam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>3-Hydroxy-4-methoxyphenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>3-Hydroxy-5α-androstan-17-one</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>3-Methoxy-4-ethoxy-α-methylphenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>3-Methoxy-4-Hydroxyamphetamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>3-Methoxy-4-Hydroxymethamphetamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>3-Methoxy-4-Hydroxyphenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>3-Methylfentanyl</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>3,4-Dichloroethylphenidate</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>3,4-Dichloromethylphenidate</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>3,4-Dichlorophenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>3,4-Dimethoxyamphetamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>3,4-Dimethoxyphenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>3,4-Methylenedioxy-N,N-dimethylamphetamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>(3,4-Methylenedioxymethamphetamine, MDMA)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>β,3,4,5-Tetramethoxyphenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>4-Androstene-3, 17-dione</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>4-Bromo-2,5-dimethoxy-α-methylphenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>4-Bromo-2,5-dimethoxyphenethylamine (2C-B)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>4-Bromo-β,2,5-trimethoxyphenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>4-Bromo-2,5-dimethoxy--methylphenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>4’-Chlorodiazepam</td>
      <td>C</td>
      <td>1</td>
    </tr>
    <tr>
      <td>4-Chloro-2,5-dimethoxyphenethylamine (2C-C)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>4-Chloromethandienone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>4-Cyano-1-methyl-4-phenylpiperidine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>4-Cyano-2-dimethylamino-4,4-diphenylbutane</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>4-Fluoroethylphenidate</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>4-Fluoromethylphenidate</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>4-Hydroxy-3-methoxyphenethylamine (HMMA)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>4-Iodo-2,5-dimethoxy-α-methylphenethyl(dimethyl)amine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>4-Methyl-aminorex</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>4-Methylmethcathinone (Mephedrone)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>4-Methylmethylphenidate</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>4-Methylthioamphetamine (α-Methyl-4-methylthio)phenethylamine</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>4-Methoxymethcathinone (bk-PMMA/methedrone)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>5-(2-Aminopropyl)indole (5-IT)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>5-Androstenedione</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>5α-Androstane-3,17-diol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>5-Androstene-3,17-diol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>5-Methoxydimethyltryptamine (5-MeO-DMT)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>(6aR,9R)-4-Acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ALD-52)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>6-(2-Aminopropyl)indole (6-IT)</td>
      <td>B</td>
      <td>1</td>
    </tr>
    <tr>
      <td>(6aR,9R) R,9R)-N,N-diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (AL-LAD)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>(6aR,9R) R,9R)-N,N-diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (PRO-LAD)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>(6aR,9R) R,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ETH-LAD)</td>
      <td>A</td>
      <td>1</td>
    </tr>
    <tr>
      <td>6-β-Hydroxytestosterone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>14-Hydroxymorphine</td>
      <td>A</td>
      <td>2</td>
    </tr>
    <tr>
      <td>19-Norandrostenedione</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>19-Norandrosterone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>19-Noretiocholanolone</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>19-Nor-5-Androstene-13,17-diol</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
    <tr>
      <td>19-Nor-4-Androstene-3,17-dione</td>
      <td>C</td>
      <td>4 Pt2</td>
    </tr>
  </tbody>
</table>

<div class="footnotes" role="doc-endnotes">
  <ol>
    <li role="doc-endnote">
      <p>Falls within paragraph 6 of Part I of Schedule 2 of the MDA 1971 (ie Class A) if in a preparation designed for administration by injection.&nbsp;<a aria-label="go to where this is referenced" class="govuk-link" href="#fnref:1" role="doc-backlink">↩</a>&nbsp;<a aria-label="go to where this is referenced 2" class="govuk-link" href="#fnref:1:1" role="doc-backlink">↩<sup>2</sup></a>&nbsp;<a aria-label="go to where this is referenced 3" class="govuk-link" href="#fnref:1:2" role="doc-backlink">↩<sup>3</sup></a>&nbsp;<a aria-label="go to where this is referenced 4" class="govuk-link" href="#fnref:1:3" role="doc-backlink">↩<sup>4</sup></a>&nbsp;<a aria-label="go to where this is referenced 5" class="govuk-link" href="#fnref:1:4" role="doc-backlink">↩<sup>5</sup></a>&nbsp;<a aria-label="go to where this is referenced 6" class="govuk-link" href="#fnref:1:5" role="doc-backlink">↩<sup>6</sup></a>&nbsp;<a aria-label="go to where this is referenced 7" class="govuk-link" href="#fnref:1:6" role="doc-backlink">↩<sup>7</sup></a>&nbsp;<a aria-label="go to where this is referenced 8" class="govuk-link" href="#fnref:1:7" role="doc-backlink">↩<sup>8</sup></a>&nbsp;<a aria-label="go to where this is referenced 9" class="govuk-link" href="#fnref:1:8" role="doc-backlink">↩<sup>9</sup></a>&nbsp;<a aria-label="go to where this is referenced 10" class="govuk-link" href="#fnref:1:9" role="doc-backlink">↩<sup>10</sup></a>&nbsp;<a aria-label="go to where this is referenced 11" class="govuk-link" href="#fnref:1:10" role="doc-backlink">↩<sup>11</sup></a></p>
    </li>
    <li role="doc-endnote">
      <p>Falls within Schedule 5 if any preparation of one or more of the substances to which this note applies, not being a preparation designed for administration by injection, when compounded with one or more other active or inert ingredients and containing a total of not more than 100 milligrams of the substance or substances (calculated as base) per dosage unit or with a total concentration of not more than 2.5 percent (calculated as base) in undivided preparations.&nbsp;<a aria-label="go to where this is referenced" class="govuk-link" href="#fnref:2" role="doc-backlink">↩</a>&nbsp;<a aria-label="go to where this is referenced 2" class="govuk-link" href="#fnref:2:1" role="doc-backlink">↩<sup>2</sup></a>&nbsp;<a aria-label="go to where this is referenced 3" class="govuk-link" href="#fnref:2:2" role="doc-backlink">↩<sup>3</sup></a>&nbsp;<a aria-label="go to where this is referenced 4" class="govuk-link" href="#fnref:2:3" role="doc-backlink">↩<sup>4</sup></a>&nbsp;<a aria-label="go to where this is referenced 5" class="govuk-link" href="#fnref:2:4" role="doc-backlink">↩<sup>5</sup></a>&nbsp;<a aria-label="go to where this is referenced 6" class="govuk-link" href="#fnref:2:5" role="doc-backlink">↩<sup>6</sup></a>&nbsp;<a aria-label="go to where this is referenced 7" class="govuk-link" href="#fnref:2:6" role="doc-backlink">↩<sup>7</sup></a>&nbsp;<a aria-label="go to where this is referenced 8" class="govuk-link" href="#fnref:2:7" role="doc-backlink">↩<sup>8</sup></a></p>
    </li>
    <li role="doc-endnote">
      <p>On 1 November 2018, Cannabis-based products for medicinal use in humans (CBPMs) were introduced under Schedule 2 to the Misuse of Drugs Regulations 2001. Only products meeting the definition of a CBPM in regulation 2(1) of the Misuse of Drugs Regulations 2001 were rescheduled. Products not meeting this definition (other than cannabis-based medicines that have received marketing authorisation and have been separately scheduled) have remained in Schedule 1 which means they cannot be accessed except under a Home Office licence.&nbsp;<a aria-label="go to where this is referenced" class="govuk-link" href="#fnref:11" role="doc-backlink">↩</a></p>
    </li>
    <li role="doc-endnote">
      <p>“Sativex” is the first cannabis-based medicine (oral spray) recognised in the UK to have medicinal properties.  Following marketing authorisation, the ACMD recommended that “Sativex” should be placed in Part I of Schedule 4 to the 2001 Regulations.&nbsp;<a aria-label="go to where this is referenced" class="govuk-link" href="#fnref:10" role="doc-backlink">↩</a></p>
    </li>
    <li role="doc-endnote">
      <p>Falls within Schedule 5 if in a preparation designed for oral administration, containing not more than 135 mg of dextropropoxyphene (calculated as base) per dosage unit or with a concentration of not more than 2.5 percent (calculated as base) in undivided preparations.&nbsp;<a aria-label="go to where this is referenced" class="govuk-link" href="#fnref:3" role="doc-backlink">↩</a></p>
    </li>
    <li role="doc-endnote">
      <p>Falls within Schedule 5 if in any preparation of difenoxin containing, per dosage unit, not more than 0.5 mg of difenoxin and a quantity of atropine sulphate equivalent to at least 5 percent of the dose of difenoxin.&nbsp;<a aria-label="go to where this is referenced" class="govuk-link" href="#fnref:4" role="doc-backlink">↩</a></p>
    </li>
    <li role="doc-endnote">
      <p>Falls within Schedule 5 if in any preparation of diphenoxylate containing, per dosage unit, not more than 2.5 mg of diphenoxylate calculated as base, and a quantity of atropine sulphate equivalent to at least 1 percent of the dose of diphenoxylate.&nbsp;<a aria-label="go to where this is referenced" class="govuk-link" href="#fnref:5" role="doc-backlink">↩</a></p>
    </li>
    <li role="doc-endnote">
      <p>GBL and 1,4-BD are not inserted into any Schedule to the 2001 Regulations. Instead, because of their legitimate industrial uses, regulation 4B of the 2001 Regulations makes it lawful to import, export, produce, supply, offer to supply or possess these substances except where a person does so knowing or believing that they will be used for the purpose of human ingestion.&nbsp;<a aria-label="go to where this is referenced" class="govuk-link" href="#fnref:9" role="doc-backlink">↩</a>&nbsp;<a aria-label="go to where this is referenced 2" class="govuk-link" href="#fnref:9:1" role="doc-backlink">↩<sup>2</sup></a></p>
    </li>
    <li role="doc-endnote">
      <p>Falls within Schedule 5 if in a preparation of medicinal opium or morphine containing (in either case) not more than 0.2 percent of morphine calculated as anhydrous morphine base, being a preparation compounded with one or more other active or inert ingredients in such a way that the opium or, as the case may be, the morphine, cannot be recovered by readily applicable means or in a yield which would constitute a risk to health.&nbsp;<a aria-label="go to where this is referenced" class="govuk-link" href="#fnref:6" role="doc-backlink">↩</a>&nbsp;<a aria-label="go to where this is referenced 2" class="govuk-link" href="#fnref:6:1" role="doc-backlink">↩<sup>2</sup></a></p>
    </li>
    <li role="doc-endnote">
      <p>Falls within Schedule 5 if in any powder of ipecacuanha and opium comprising: 10 percent opium, in powder, 10 percent ipecacuanha root, in powder, well mixed with 80 percent of any other powdered ingredient containing no controlled drug.&nbsp;<a aria-label="go to where this is referenced" class="govuk-link" href="#fnref:7" role="doc-backlink">↩</a></p>
    </li>
    <li role="doc-endnote">
      <p>Falls within Schedule 5 if in a preparation containing, per dosage unit, not more than 100 mg of propiram calculated as base and compounded with at least the same amount (by weight) of methylcellulose.&nbsp;<a aria-label="go to where this is referenced" class="govuk-link" href="#fnref:8" role="doc-backlink">↩</a></p>
    </li>
  </ol>
</div>
</div>


</div>
</div>
    </div>
  </div>

  <div class="govuk-grid-row">
    <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg class="app-c-back-to-top__icon" focusable="false" height="17" viewBox="0 0 13 17" width="13" xmlns="http://www.w3.org/2000/svg">
      <path d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z" fill="currentColor"></path>
    </svg>
    Back to top
</a>

  </div>
</div>

    </main>